InsiderTradesSIGMA

PicksTOP Companies Executives Performance Blog Topics

InsidersTradesSigma

InsiderTradesSIGMA

Multi-market insider intelligence. Official public filings, re-aggregated and scored. Private beta.

FRUSDEGBCHCAITESNLBENOSEFIDKAUATIEBRINJP+ 8 markets

Recommendations
Companies
Insiders
Performance
Backtest
Compare

Methodology
How it works
Glossary
API docs
Status
Blog

Sign in
Create account
Portfolio
API keys
Alerts
Upgrade

Privacy
Terms
Cookies
Contact
About

Built in Paris. Public sources across 28 markets: AMF France, SEC EDGAR Form 4 US, BaFin Germany, SIX SER Switzerland, RNS United Kingdom, SEDI Canada, Consob Italy, CNMV Spain, AFM Netherlands, FSMA Belgium, Oslo Bors Norway, Nasdaq Helsinki, Nasdaq Copenhagen, ASX Australia, FMA Austria, CVM Brazil, HKEX Hong Kong, BSE-Sofia Bulgaria, Tadawul Saudi Arabia, DART South Korea, EDINET Japan, SSE and SZSE China, SEBI India, KNF Poland, PSE Philippines, NZX New Zealand, JSE South Africa. Prices + fundamentals via Yahoo Finance, STOXX 600 sector ETFs (iShares Xetra). Stack: Next.js 16, Prisma, Vercel. Live out-of-sample tracker since 2026-05-16. Methodology audits: /methodologie and /docs/method-review/.

Sources: official public filings under MAR Art.19 (EU and EEA), SEC Section 16 / Form 4 (US), Art.56 SESTA (CH, SIX SER), NI 55-104 / SEDI (CA), Corporations Act s205G (AU) and equivalent regimes. Signals on this site are for educational use only and do not constitute investment advice within the meaning of MiFID II / SEC Reg-IA. Past performance does not guarantee future results. Swiss SIX SER filings are anonymised by law (role only, no name).

Theme: dark (range regime detected on CAC40 90d · as of 2026-05-22)

© 2026 Insiders TradesΣ·Private beta·Hosted on Vercel

All systems operational

InsidersTradesSigma

Michael Engsig — reported transactions · 5 disclosures

← Executives ★ Sign in to follow

ME

Michael Engsig

NONO·Oslo Børs

Nykode Therapeutics ASA

Cumul. flow

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Browse the full record of transactions filed by Michael Engsig. Insider active across 1 companies, notably Nykode Therapeutics ASA. Aggregated, 5 reports have been published. The latest transaction was filed on 24 November 2025 — Purchase. Regulator: Oslo Børs. The full history is accessible without signup.

Declarations5 total

Executives●PurchaseNNykode Therapeutics ASA0Oslo

M

€8,49046,356 shares@ €0.1831

ShareXOSL

OSLO:660428·24 Nov 2025

Ideal exit: 21 Aug 2026 (T+270)

Executives●PurchaseNNykode Therapeutics ASA0Oslo

M

€8,59955,944 shares@ €0.1537

ShareXOSL

OSLO:656985·10 Oct 2025

Ideal exit: 7 Jul 2026 (T+270)

Executives●PurchaseNNykode Therapeutics ASA0Oslo

M

€8,7296,000 shares@ €1.4549

ShareXOSL

OSLO:612321·29 Feb 2024

Ideal exit: 25 Nov 2024 (T+270)

Executives●OtherNNykode Therapeutics ASA0Oslo

M

OptionXOSL

OSLO:604960·30 Dec 2023

Executives●PurchaseNNykode Therapeutics ASA0Oslo

M

€14,2349,850 shares@ €1.4451

ShareXOSL

OSLO:602645·31 Oct 2023

Ideal exit: 27 Jul 2024 (T+270)

5 of 5 declarations